Open Access

Time to Take the Lead – Practical Utilization of SGLT2 Inhibitors

Event: ESC CONGRESS 2020 - The Digital Experience
Topic: Pharmacotherapy
Session type: Industry Q&A session
Organised by Radcliffe Medical Education, supported by Boehringer Ingelheim & Eli Lilly and Company Alliance in the form of an educational grant
Date: 31 August 2020
Time: 18:30 - 19:30

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

5 presentations in this session

Session Introduction.

Speaker: Professor J. Butler (Jackson, US)
Thumbnail

No Permission Needed.

Speaker: Doctor S. Zieroth (Winnipeg, CA)
Thumbnail

SGLT2i are Cardiovascular Drugs

Speaker: Professor J. Butler (Jackson, US)
Thumbnail

Cardiologist Taking the Lead – Practical Initiation and Management

Speaker: Professor S. Anker (Berlin, DE)
Thumbnail

Live panel discussion and close.

Speaker: Doctor S. Zieroth (Winnipeg, CA)
Speaker: Professor J. Butler (Jackson, US)
Speaker: Professor S. Anker (Berlin, DE)
Thumbnail

7 speakers from this session

Professor Javed Butler

The University of Mississippi Medical Center, Jackson (United States of America)
60 presentations
3 followers

Doctor Shelley Zieroth

University of Manitoba, Winnipeg (Canada)
18 presentations
0 follower

Professor Javed Butler

The University of Mississippi Medical Center, Jackson (United States of America)
60 presentations
3 followers

Professor Stefan Anker

Charite Campus Virchow Clinic, Berlin (Germany)
104 presentations
3 followers

Doctor Shelley Zieroth

University of Manitoba, Winnipeg (Canada)
18 presentations
0 follower

Professor Javed Butler

The University of Mississippi Medical Center, Jackson (United States of America)
60 presentations
3 followers

Professor Stefan Anker

Charite Campus Virchow Clinic, Berlin (Germany)
104 presentations
3 followers

Related content

ESC Premium Access

Young Cardiologists Clinical Case Competition

4 December 2021

ESC Premium Access

Current controversies in antithrombotic therapy

3 December 2021

This platform is supported by

logo Novo Nordisk